logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • Nonergot Dopamine Agonist class drugs

    FiltersReset Filters
    7 results

    • neupro

      (rotigotine)
      UCB, Inc.
      Usage: NEUPRO is indicated for the treatment of Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome (RLS).

    • pramipexole dihydrochloride

      (Pramipexole Dihydrochloride)
      Rising Pharma Holdings, Inc.
      Usage: Pramipexole dihydrochloride tablets are indicated for the treatment of Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome (RLS).

    • pramipexole dihydrochloride

      (Pramipexole dihydrochloride)
      Glenmark Pharmaceuticals Inc., USA
      Usage: Pramipexole dihydrochloride tablets are indicated for the treatment of Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome (RLS).

    • pramipexole dihydrochloride

      (Pramipexole Dihydrochloride)
      ScieGen Pharmaceuticals Inc
      Usage: Pramipexole dihydrochloride tablets are indicated for the treatment of Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome (RLS).

    • ropinirole

      (ropinirole)
      Glenmark Pharmaceuticals Inc., USA
      Usage: Ropinirole tablets are indicated for the treatment of Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome (RLS).

    • ropinirole

      (Ropinirole)
      Alembic Pharmaceuticals Inc.
      Usage: Ropinirole extended-release tablets are indicated for the treatment of Parkinson's disease.

    • ropinirole

      (ropinirole)
      Marlex Pharmaceuticals Inc
      Usage: Ropinirole tablets are indicated for the treatment of Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome (RLS).